Trial Profile
Long term survival outcomes in patients with Adult Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia treated with Imatinib or Dasatinib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary) ; Imatinib
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 20 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association.